Iwanaga Y, Ueno M, Ueki M, Huang C-L, Tomita S, Okamoto Y, Ogawa T, Ueda N, Maekawa N, Sakamoto H
Department of Anaesthesiology and Emergency Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Neuropathol Appl Neurobiol. 2008 Apr;34(2):145-54. doi: 10.1111/j.1365-2990.2007.00877.x. Epub 2007 Oct 31.
We previously reported that the blood-brain barrier (BBB) function was deteriorated in vessels located along hippocampal fissures in stroke-prone spontaneously hypertensive rats (SHRSP). In this study, we examined changes of gene expression in the BBB-damaged vessels of SHRSP.
Vascular samples were microdissected from the hippocampi of SHRSP and Wistar-Kyoto (WKY) as a control and the difference in gene expression between the BBB-damaged vessels in SHRSP and vessels without BBB damage in WKY was examined by a microarray. The differences in gene and protein expression between brain tissues in the two strains of rats were examined using real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), Western blotting and immunohistochemistry.
The microarray assay revealed that the ratio of osteopontin gene expression in the vascular tissue of the hippocampi of SHRSP to that of WKY was the highest among 8435 genes. Real-time RT-PCR analysis revealed that the gene expression of osteopontin was significantly increased in the hippocampal samples of SHRSP compared with that in the hippocampal samples of WKY rats or with that in the cortical samples of SHRSP. Immunohistochemical and Western blot analyses showed that the osteopontin protein expression was seen in perivascular ED1-positive macrophages/microglial cells located around hippocampal fissures and significantly increased in the hippocampi of SHRSP compared with that of WKY.
These findings indicate that the expression of osteopontin is increased in BBB-damaged vessels in hypertensive SHRSP compared with that in vessels without BBB impairment in WKY rats, suggesting a role for osteopontin in BBB function.
我们之前报道过,在易中风自发性高血压大鼠(SHRSP)中,位于海马裂周围的血管中血脑屏障(BBB)功能会恶化。在本研究中,我们检测了SHRSP中血脑屏障受损血管的基因表达变化。
从SHRSP和作为对照的Wistar-Kyoto(WKY)大鼠的海马中显微切割血管样本,通过微阵列检测SHRSP中血脑屏障受损血管与WKY中未受损血管之间的基因表达差异。使用实时定量逆转录聚合酶链反应(RT-PCR)、蛋白质印迹法和免疫组织化学检测两株大鼠脑组织之间基因和蛋白质表达的差异。
微阵列分析显示,在8435个基因中,SHRSP海马血管组织中骨桥蛋白基因表达与WKY的比值最高。实时RT-PCR分析显示,与WKY大鼠海马样本或SHRSP皮质样本相比,SHRSP海马样本中骨桥蛋白的基因表达显著增加。免疫组织化学和蛋白质印迹分析表明,在海马裂周围的血管周围ED1阳性巨噬细胞/小胶质细胞中可见骨桥蛋白的蛋白质表达,与WKY相比,SHRSP海马中骨桥蛋白的表达显著增加。
这些发现表明,与WKY大鼠中未受损的血管相比,高血压SHRSP中血脑屏障受损血管中骨桥蛋白的表达增加,提示骨桥蛋白在血脑屏障功能中发挥作用。